Metraipolis › archive › dc_700b36d07188

Documenting Trofinetide Treatment Phenotypes in Rett Syndrome with a Dual-LLM Consensus Pipeline — arXiv:2610.22062

Source
arXiv (en)
Original
https://arxiv.org/abs/2610.22062
License (as archived)
CC0-1.0
Archived
2026-10-16T10:04:19.765Z
SHA-256 of the archived text
293b3d740f607a3caf15ad320ee08b631df4040bef5a378cc1bbe04b9de45b84
Stable URL of this page
https://metraipolis.com/documento/dc_700b36d07188

How to cite

Documenting Trofinetide Treatment Phenotypes in Rett Syndrome with a Dual-LLM Consensus Pipeline — arXiv:2610.22062 — arXiv (en), https://arxiv.org/abs/2610.22062 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_700b36d07188 (Metraipolis archive dc_700b36d07188, sha256 293b3d740f607a3caf15ad320ee08b631df4040bef5a378cc1bbe04b9de45b84)
BibTeX
@misc{dc700b36d07188,
  title = {Documenting Trofinetide Treatment Phenotypes in Rett Syndrome with a Dual-LLM Consensus Pipeline — arXiv:2610.22062},
  howpublished = {arXiv (en)},
  url = {https://arxiv.org/abs/2610.22062},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_700b36d07188; sha256 293b3d740f607a3caf15ad320ee08b631df4040bef5a378cc1bbe04b9de45b84},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2610.22062. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Objective: Trofinetide, approved in 2023 as the first Rett syndrome treatment, lacks scalable real-world monitoring because chart review is labor-intensive. We developed a dual large language model (LLM) consensus pipeline to extract 18 treatment-response phenotypes, comprising 4 adverse effects, 13 Rett clinical features, and medication refusal, from clinical notes. Materials and Methods: We analyzed 26,763 notes from 108 patients with confirmed sustained trofinetide exposure at Texas Children's Hospital. The pipeline filters notes by keyword, classifies each through two LLMs requiring consensus, and aggregates a patient-by-timepoint matrix. Architecture and prompt were selected on a diarrhea development set, then frozen and applied to the other 17 phenotypes with the phenotype definition substituted, as an out-of-sample test. The reported prompt comparison scores 183 expert-labeled cells. Results: A prompt requiring diarrhea to be active and severe performed best (84.2 $\pm$ 0.0% accuracy; F1 = 0.674), 47 percentage points above regular-expression matching ($p < 0.0001$). Expert reviewers judged six of the pipeline's calls per phenotype, three positive and three negative, and agreed with 90.2% (92/102). The 13 Rett clinical features are manifestations of the disorder itself rather than adverse effects of trofinetide. Gross and fine motor impairment, language/communication, and stereotypy were documented present in 92-100% of patients at every visit. Discussion: In-context LLM extraction captured multi-domain treatment responses. The outcome is documented presence at each visit, not a direction-of-change judgment. Conclusion: Coupling in-context LLM reasoning with a consensus architecture offers a scalable alternative to keyword and regular-expression extraction for real-world evidence, adapting to new phenotypes and medications through configuration alone.

Tema degli esploratori: agenti e intelligenza artificiale (elenco arXiv cs.CL, nuovi lavori del giorno).
Categorie arXiv: Quantitative Methods (q-bio.QM) ; Computation and Language (cs.CL).
Pagina del lavoro: https://arxiv.org/abs/2610.22062 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina.
Letto il 2026-10-16T08:44:47.772Z dalla pagina https://arxiv.org/list/cs.CL/new (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).